The Tel Aviv-based company said the technology enhances the precision and efficiency of tools like CRISPR, accelerating the development of traits such as drought tolerance, yield improvement, and ...

Researchers from MIT have incorporated several modifications to prime editing systems, making them up to 60 times more ...

THEY look like ordinary foals, docile with honey brown coats and white facial patches, content to spend their days munching alfalfa in a cordoned-off pasture in rural Buenos Aires province.

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

CRISPR Therapeutics (SRSP) stock gains as the company gets a new Overweight rating from J.P. Morgan thanks to its therapeutic ...

Colossal Biosciences says it’s one step closer to bringing back the dodo. In April, the Dallas company said it had revived ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced it has completed enrollment in ...